ERBB2 and breast carcinoma: Here, we found that BTG1 mRNA expression was remarkably linked to the infiltration of immune cells, Her2 expression and molecular subtyping of breast cancer, demonstrating that BTG1 would be employed to guide the target therapy for breast cancer patients.